Novel synthetic process for the core structure of the fungal antiviral agent neoechinulin B and its derivatives

The fungus-derived compound neoechinulin B demonstrates promising antiviral activity. To realize its potential as an antiviral agent, however, a viable method for preparing more potent derivatives synthetically is necessary. In a recent breakthrough, scientists from Japan designed a simple route for synthesizing neoechinulin B and its derivatives under mild laboratory conditions. Neoechinulin B and six derivatives exhibited excellent antiviral activities against hepatitis C virus and SARS-CoV-2, the virus responsible for the COVID-19 pandemic.